Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants. J of Skin [Internet]. 2023 Jul. 17 [cited 2025 Apr. 18];7(4):s227. Available from: https://skin.dermsquared.com/skin/article/view/2202